Registration
Coffee and juice will be available

Perspectives in Global Health: Helping without Hurting

ACPE# 0046-0000-12-066-L04-P
1.0 contact hour or 0.10 CEUs
Jeffrey E. Heck, MD
President and CEO, Mountain Area Health Education Center (MAHEC)

Objectives

• Recognize and recall the concept of community-oriented health projects and how to interact with resource-poor communities with cultural humility.
• Through case studies, illustrate and identify the concepts of community assessment, the social determinants of health and health systems in poor countries.
• Through case studies, review and recall a range of ways that pharmacists can make a meaningful contribution to a resource-poor community.

New Drugs

ACPE# 0046-0000-12-058-L01-P
1.0 contact hour or 0.10CEUs
Stephen Eckel, PharmD, MHA, BCPS
Assistant Director of Pharmacy, UNC Hospitals

Objectives

• Name 5 drugs that recently have received FDA approval that are or likely will be prescribed or dispensed from their practice and list their dosage forms.
• Compare and contrast their role in practice with existing medications similar indications.
• Discuss dosing, cautions, side effects and primary points of patient education for these medications.

Break
Refreshments will be available

Updates in Heart Failure Management

ACPE# 0046-0000-12-049-L01-P/T
1.0 contact hour or 0.10 CEUs
Bill Hitch, PharmD, BCPS, CPP
Director of Pharmacotherapy, Mountain AHEC

Objectives

• Describe the pathophysiologic changes that lead to heart failure.
• Identify appropriate medications to decrease morbidity and mortality in patient with heart failure.
• Describe non-pharmacologic interventions for patients with heart failure.

"Are you Diabetic?": An Update on individualized diabetes therapy

ACPE# 0046-0000-12-063-L01-P
1.0 contact hour or 0.10 CEUs
Caron Misita, PharmD, BCPS, CDE,CPP
Clinical Pharmacist, Highgate Specialty Center, Diabetes Care & Endocrinology

Objectives

• Describe appropriate therapeutic glucose targets for various types of patients with Diabetes.
• Discuss relevant points related to dispensing, patient counseling, and use of the non-insulin injectable therapies for diabetes.
• Discuss reasonable steps for escalation in the treatment of diabetes.
• Summarize controversies and appropriate solutions regarding safe use of U500 concentrated insulin in the outpatient environment.

Q&A and Evaluation

Registration
Coffee and juice will be available

Disaster Preparedness for Pharmacists

ACPE# 0046-9999-12-064-L04-P
1.0 contact hour or 0.10 CEUs
Greene Shepard, PharmD
Director of Professional Education, UNC School of Pharmacy Asheville Campus

Objectives

• Identify disasters and threats that are specific to your practice area.
• Define the role(s) of pharmacists in different disaster scenarios.
• Describe the process for pharmacists to effectively participate in disaster relief efforts.

Contemporary Issues in Contraception

ACPE# 0046-0000-12-070-L04-P
1 contact hour or 0.10 CEUs
Mollie A. Scott, PharmD, BCPS,CPP
Regional Associate Dean
UNC Eshelman School of Pharmacy, Asheville Campus

Objectives

• Compare and contrast available prescription contraceptive agents with regards to potential adverse drugs events, missed doses, and appropriate administration.
• Counsel a patient about the appropriate use of emergency contraception.
• Recommend a contraceptive agent for women with special circumstances including thromboembolic disease, breastfeeding, and perimenopause.

Break
Refreshments will be available

Workshop No. 1
The Challenge of Clostridium difficile Infection

ACPE# 0046-0000-12-062-L01-P
1.5 contact hour or 0.15 CEUs
Ralph Raasch, PharmD
Associate Professor, UNC Eshelman School of Pharmacy

Objectives

• Review and discuss the risk factors, pathophysiology and microbiology associated with the development of Clostridium difficile infection.
• Given a patient case, recognize the signs, symptoms, and laboratory tests consistent with C. difficile infection.
• Evaluate the clinical outcome differences between several available treatment options, including metronidazole, vancomycin and fidazomicin.  Given a patient case with C.
• difficile infection, recommend the most appropriate therapy for that patient.

Workshop No. 2
Practical Pharmacotherapy Considerations in the Treatment of Patients with Asthma or COPD

ACPE # 0046-0000-12-068-L01-P
1.5 contact hours or 0.15 CEUs
Dennis Williams, PharmD
Associate Professor, UNC Eshelman School of Pharmacy

Objectives

• Identify relevant counseling and monitoring points related to pharmacotherapy of asthma and COPD.
• Describe the rationale for a stepwise approach in using medications for asthma and COPD.
• Discuss challenges and solutions related to pharmacotherapy for asthma and COPD.